Literature DB >> 20951638

Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.

Max Schobert1, Dieter Jahn.   

Abstract

During chronic infection of the cystic fibrosis (CF) lung, Pseudomonas aeruginosa grows and persists in a microaerobic to anaerobic environment. P. aeruginosa is well adapted to thrive under such conditions and contains multiple enzyme systems for energy generation under oxygen-restricted or even anaerobic conditions. Recent data confirm a heterogeneous environment in the CF lung and indicate that P. aeruginosa induces enzyme systems for microaerobic growth but also denitrification and fermentative pathways. Moreover, stress response systems as universal stress proteins enhance survival under anaerobic energy starvation conditions. Growth in these oxygen-limited environments induces a drastic physiological change in P. aeruginosa, like increased alginate production and alterations in the outer membrane, which contribute to an increased antibiotic tolerance.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951638     DOI: 10.1016/j.ijmm.2010.08.007

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  68 in total

1.  Antibiofilm Efficacy of Nitric Oxide-Releasing Alginates against Cystic Fibrosis Bacterial Pathogens.

Authors:  Mona Jasmine R Ahonen; Jamie M Dorrier; Mark H Schoenfisch
Journal:  ACS Infect Dis       Date:  2019-06-11       Impact factor: 5.084

2.  Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa.

Authors:  Kang-Mu Lee; Junhyeok Go; Mi Young Yoon; Yongjin Park; Sang Cheol Kim; Dong Eun Yong; Sang Sun Yoon
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

3.  Medium factors on anaerobic production of rhamnolipids by Pseudomonas aeruginosa SG and a simplifying medium for in situ microbial enhanced oil recovery applications.

Authors:  Feng Zhao; Jidong Zhou; Siqin Han; Fang Ma; Ying Zhang; Jie Zhang
Journal:  World J Microbiol Biotechnol       Date:  2016-02-29       Impact factor: 3.312

4.  Enzyme-encapsulating polymeric nanoparticles: A potential adjunctive therapy in Pseudomonas aeruginosa biofilm-associated infection treatment.

Authors:  Chendong Han; James Goodwine; Nicholas Romero; Kyle S Steck; Karin Sauer; Amber Doiron
Journal:  Colloids Surf B Biointerfaces       Date:  2019-09-20       Impact factor: 5.268

5.  Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population.

Authors:  Kerry S Williamson; Lee A Richards; Ailyn C Perez-Osorio; Betsey Pitts; Kathleen McInnerney; Philip S Stewart; Michael J Franklin
Journal:  J Bacteriol       Date:  2012-02-17       Impact factor: 3.490

6.  Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology.

Authors:  Philip S Stewart; Ben White; Laura Boegli; Timothy Hamerly; Kerry S Williamson; Michael J Franklin; Brian Bothner; Garth A James; Steve Fisher; Francisco G Vital-Lopez; Anders Wallqvist
Journal:  J Bacteriol       Date:  2019-10-21       Impact factor: 3.490

Review 7.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

8.  Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.

Authors:  Jeremy R Dettman; Nicolas Rodrigue; Shawn D Aaron; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

9.  The Pseudomonas aeruginosa CreBC two-component system plays a major role in the response to β-lactams, fitness, biofilm growth, and global regulation.

Authors:  Laura Zamorano; Bartolomé Moyà; Carlos Juan; Xavier Mulet; Jesús Blázquez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

10.  Predominant pathogen competition and core microbiota divergence in chronic airway infection.

Authors:  Geraint B Rogers; Christopher J van der Gast; David J Serisier
Journal:  ISME J       Date:  2014-07-18       Impact factor: 10.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.